Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta

Ítems similars

• Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
  per: Hannan, Natalie J., et al.
  Publicat: (2017)
• MMP-15 Is Upregulated in Preeclampsia, but Does Not Cleave Endoglin to Produce Soluble Endoglin
  per: Kaitu’u-Lino, Tu’uhevaha J., et al.
  Publicat: (2012)
• Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia
  per: Hannan, Natalie J., et al.
  Publicat: (2018)
• Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction – implications for treating preeclampsia
  per: Kaitu’u-Lino, Tu’uhevaha J., et al.
  Publicat: (2018)
• The Effect of Immune Factors, Tumor Necrosis Factor-α (TNF-α), and Agonistic Autoantibodies to the Angiotensin II Type I Receptor (AT1-AA) on Soluble fms-Like Tyrosine-1 (sFlt-1) and Soluble Endoglin (sEng) Production in Response to Hypertension During Pregnancy
  per: Parrish, Marc R., et al.
  Publicat: (2010)